W
Wuxi Cancer Intelligent Drive Technology
Precision components for robotics and intelligent manufacturing
About Wuxi Cancer Intelligent Drive Technology
Wuxi Cancer Intelligent Drive Technology Co., Ltd., also known as Juxie Intelligent or CrabNova, was established in 2019 in Wuxi, China. The company operates as a key intelligent manufacturing enterprise in Jiangsu Province. The legal representative is Zhao Wei. Juxie Intelligent specializes in the research, development, and industrialization of core components for the robotics industry, with a particular focus on humanoid robots.
The company's business model centers on the full-stack development and mass production of critical robotic parts. Its main products include series harmonic reducers, micro low-voltage servo drivers, integrated encoders, force sensor components, and integrated power joint modules. These components are crucial for the performance of high-end robotics. Juxie Intelligent controls key technologies across the production chain, including raw materials, heat treatment, processing, and design simulation.
Juxie Intelligent serves a broad market, with its products being applied in robotics, drones, industrial intelligent manufacturing, security and emergency services, medical applications, and scientific research and education. In late 2025, the company announced the completion of a nearly CNY 100 million Series A financing round led by a strategic investment from Ecovacs, with participation from other industrial resource parties. This funding underscores market confidence in the company's technical expertise and commercialization capabilities. Juxie Intelligent operates an 8,000-square-meter research and development base to support its manufacturing and customer service operations.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2025 | — | — | Zijin Science and Technology | ↗ |
| SERIES A✓Equity / VC | Oct 2025 | $14M | $55M | Shanghai Heyin Investment · Ecovacs | ↗ |
Growth signals
Latest recorded traffic for Wuxi Cancer Intelligent Drive Technology is 40 monthly website visits, down 93.2% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Shenzhen Capital Group
Ecovacs- SIShanghai Heyin Investment
- ZTZijin Science and Technology
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Wuxi Cancer Intelligent Drive Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Wuxi Cancer Intelligent Drive Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







